Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6483
Peer-review started: August 19, 2021
First decision: January 10, 2022
Revised: January 24, 2022
Accepted: May 27, 2022
Article in press: May 27, 2022
Published online: July 6, 2022
Processing time: 309 Days and 0.4 Hours
Colorectal cancer is a common, high-mortality cancer. Classified by the World Health Organization as a single entity, colon cancer and rectal cancer are largely different in their diagnoses, treatments, surgical methods, and recurrence rates. Since early symptoms are easily overlooked, it is important to find a more accurate staging method.
By looking for a method to detect local stages of colon cancer, we hoped to find a method that has better accuracy and can distinguish between high-risk and low-risk colon cancer.
This study aimed to evaluate the diagnostic accuracy of ≥ 16-slice spiral computed tomography (SCT) in detecting local colon cancer staging.
Based on the PubMed, EMBASE, Cochrane Library, and Web of Science databases, computers were used to search the literature from the establishment of the database to April 2021. The results of the diagnostic tests on ≥ 16-slice SCT for local colon cancer staging were collected according to the inclusion criteria, and then the data were extracted and assessed on the basis of the Quality Assessment Checklist of the Institute of Economics of Canada. Afterward, a meta-analysis was performed using the statistical software Meta-disc 14.0 and Stata 15.0.
Eleven studies with a total of 1613 subjects were included. The pooled sensitivity, pooled specificity, pooled negative LR, pooled diagnostic odds ratio, and the area under the fitted receiver operating characteristic curve of ≥ 16-slice SCT for colon cancer T staging and N staging were analyzed. The results revealed that the sensitivity and specificity of ≥ 16-slice SCT for colon cancer T staging were acceptable, while the sensitivity of colon cancer N staging was relatively low, but its specificity was acceptable.
It was revealed in this study that the sensitivity and specificity of ≥ 16-slice SCT for colon cancer T staging are acceptable, while there is a relatively low sensitivity and specificity for colon cancer N staging, which is indicative of the good diagnostic value of ≥ 16-slice SCT for local staging of colon cancer. These findings need to be confirmed in further clinical studies.
In the future, further clinical studies should be carried out to prove the accuracy of 16-slice SCT for local staging of colon cancer.